PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.\', \'Clinical Epidemiology Unit, National Institute for Infectious Disease Lazzaro Spallanzani-IRCCS, Rome, Italy.\', \'UOS Professioni Sanitarie Tecniche National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.\', \'Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy.\', \'UOC Transfusion Medicine and Stem Cell Unit, San Camillo Forlanini Hospital, Rome, Italy.\', \'Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.\', \'Scientific Direction, National Institute for Infectious Disease \'Lazzaro Spallanzani\'-IRCCS, Rome, Italy.\', \'Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy. delia.goletti@inmi.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12967-021-02938-8
?:hasPublicationType
?:journal
  • Journal of translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 34174875
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.565
?:rankingScore_hIndex
  • 81
is ?:relation_isRelatedTo_publication of
?:title
  • Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34174875>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34174875>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all